Navigation Links
SyntheMed Completes $2.8 Million Equity Financing
Date:9/3/2007

ISELIN, N.J., Aug. 14 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), today announced that it has completed the initial closing of a private placement in which it received $2.8 million in gross proceeds. Robert P. Hickey, the Company's President and CEO, stated, "The proceeds of this financing will help fund the US launch of REPEL-CV(R) Adhesion Barrier planned for the fourth quarter of this year."

At the closing, the Company issued and sold 2.8 million shares of Common Stock at $1.00 per share to a consortium of accredited overseas investors. The Company has authorized the sale of an additional 3.2 million shares in the private placement on the same terms. The Company has agreed to file a registration statement with the SEC covering the resale of the privately-placed shares within thirty days following final closing of the placement, which is anticipated to occur on or before August 31, 2007.

The securities offered in the private placement have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products based on its proprietary bioresorbable polymer technology.

Statements in this Press Release that are not statements of historical fact, including statements regarding indications of the timing or ability to achieve regulatory approval and market launch for REPEL-CV or the potential market size for REPEL-CV, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future re
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology news :

1. Worlds largest rainforest drying experiment completes first phase
2. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
3. Sandia completes depleted uranium study
4. LIAI completes worlds most comprehensive analysis on influenza virus data
5. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
6. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
7. Six million Africans face famine because of locusts, drought
8. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
9. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
10. $5.1 billion would save 6 million children
11. Health costs soar as 60 million Americans classed as obese
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...e, scientists have found black smoker vents farthe...ter of five vents one towering nearly four storie... Dissolved sulfide minerals that solidify when ven...er the years, accumulated around the vent field in...ide deposits ever found on the seafloor, according...
(Date:7/24/2008)...rchers from Columbia University,s Mailman School o...ing issues in infant health and preventing mother-...hese settings, HIV-infected mothers had been advis...ey should exclusively breast-feed, followed by a r...ccording to the study conducted in Lusaka, Zambia ...
(Date:7/24/2008)...life of a cell, the response to DNA damage determi...itself, commit suicide, or grow uncontrollably, a ... in the July 25th issue of Cell , scientists at N...at cells respond to DNA damage through a process t...nts to a new pathway for the development of cancer...
(Date:7/24/2008)...08) A multi-institutional team of researchers, in...Medical School, have developed a powerful tool for...will allow researchers to generate synthetic enzym...r inactivation or repair. , The potential for dis...of the Arnold and Mabel Beckman Center for Transpo...
Breaking Biology News(10 mins):Scientists break record by finding northernmost hydrothermal vent field 2Scientists break record by finding northernmost hydrothermal vent field 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3A new cellular pathway linked to cancer is identified by NYU researchers 2Consortium develops new method to manipulate genetic material 2WuXi PharmaTech Announces Second Quarter 2007 Results 390 1WuXi PharmaTech Announces Second Quarter 2007 Results 390 2WuXi PharmaTech Announces Second Quarter 2007 Results 390 3WuXi PharmaTech Announces Second Quarter 2007 Results 390 4WuXi PharmaTech Announces Second Quarter 2007 Results 390 5WuXi PharmaTech Announces Second Quarter 2007 Results 390 6WuXi PharmaTech Announces Second Quarter 2007 Results 390 7WuXi PharmaTech Announces Second Quarter 2007 Results 390 8WuXi PharmaTech Announces Second Quarter 2007 Results 390 9WuXi PharmaTech Announces Second Quarter 2007 Results 390 10Results from Study Evaluating PROCRIT 28R 29 in Intensive Care Unit Patients Published in New England Journal of Medicine 201 1Results from Study Evaluating PROCRIT 28R 29 in Intensive Care Unit Patients Published in New England Journal of Medicine 201 2Results from Study Evaluating PROCRIT 28R 29 in Intensive Care Unit Patients Published in New England Journal of Medicine 201 3Results from Study Evaluating PROCRIT 28R 29 in Intensive Care Unit Patients Published in New England Journal of Medicine 201 4Results from Study Evaluating PROCRIT 28R 29 in Intensive Care Unit Patients Published in New England Journal of Medicine 201 5Results from Study Evaluating PROCRIT 28R 29 in Intensive Care Unit Patients Published in New England Journal of Medicine 201 6Drug Pacemaker Fight Irregular Heartbeat 605 1Drug Pacemaker Fight Irregular Heartbeat 605 2Drug Pacemaker Fight Irregular Heartbeat 605 3Genes Boost Risk for Rheumatoid Arthritis Lupus 603 1Genes Boost Risk for Rheumatoid Arthritis Lupus 603 2Genes Boost Risk for Rheumatoid Arthritis Lupus 603 3Genes Boost Risk for Rheumatoid Arthritis Lupus 603 4
... found that the neurotransmitter serotonin, known ...lasting, quality sleep in an animal model for unde... the lives of most animals, the proper regulation ...findings are reported by Quan Yuan, William Joiner...ia, and appear in the June 6th issue of Current Bi...
...st Nile Virus appears to be triggered by a complex...ific weather patterns, scientists say, which leads...opulations. , Researchers from Oregon State Univer... how those factors mesh to create heightened risk ...ey hope to expand their studies to the rest of the...
...erson,s real age? Just look at their hands, report...ructive Surgery®, the official medical journal of ...According to the study, most people can accurately..., "A primary motivation to have plastic surgery is...er looking appearance. However, looking younger a...
...ribe the discovery of a novel class of mutations t...se a specific phenotype. The mutation created the ...ecognition site in a gene that did not have it in ...d is the myostatin. This gene is expressed in the ...otein is to inhibit muscular growth. The mutation ...
Other Biology News:New strategy developed to combat West Nile Virus 2New strategy developed to combat West Nile Virus 3The appearance of your hands can reveal your age, study finds 2
(Date:7/24/2008)...re/ -- The Global Probiotics Council,(GPC), a comm...ult Honsha,Co., Ltd., announced the two awardees w...rant for Probiotics Research (YIGPRO) today. The p...who will continue to contribute to,the advancement...United,States., Ajay S. Gulati, MD, an Assistant ...
(Date:7/24/2008)... Important Advance in Radiofrequency ...if., July 24 /- PEAK Surgical, Inc., ...tissue dissection system,based on a proprietary te...rug Administration has granted the company 510(k) ... use in general surgery. The PEAK Surgery System,c...
(Date:7/24/2008)...ire/ -- Sagent Pharmaceuticals, Inc.,a privately-...nced that it,has launched ceftazidime for injectio...m antibiotic. Sagent will offer ceftazidime in 1,a...ge vials. According to,IMS data, 2007 sales of inj...ximately $45.7 million., "Sagent is proud to be p...
(Date:7/24/2008)...swire-FirstCall/ -- United,Therapeutics Corporatio...lease its 2008 second quarter financial results be...., United Therapeutics will host a half-hour tele.... Eastern Time. The teleconference is accessible,b...rs dialing,1-706-679-8129. A rebroadcast of the te...
Breaking Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
...n a line of reports paints a bleak picture for ent...uggesting that such financing could be at its lowe... quarter continue to year,s end. , ,The Money Tre...opers, Thomson Venture Economics and the National ...s millions of additional dollars is invested in Wi...
...golden haze surrounding the mystic city of Tunisia...ion age will once again try to figure out the futu...o will control the "naming system," the basic earl...d domain name management. , ,The politico-technocr...ure on this issue. In November, they will fight ou...
..., Wis. - Former New York City Mayor Rudolph Giuli...oration,s ninth annual user conference and logist... and Spa in Tucson, Arizona, May 9-12, 2006. , ,G...government and private sectors can transform their...rie provides industry-tailored supply-chain soluti...
...n, Wis. After Gov. Jim Doyle vetoed a bill that ...cells for research purposes, the legislative direc...mark that seemed straight out of a science fiction...ore; we,re talking about growing these embryos . ....s, Right to Lifes Sue Armacost was quoted as sayin...
Other Biology Technology:While some bemoan lack of venture capital, entrepreneur touts `bootstrapping' for cash 2While some bemoan lack of venture capital, entrepreneur touts `bootstrapping' for cash 3While some bemoan lack of venture capital, entrepreneur touts `bootstrapping' for cash 4The winners and losers of the internet break-up 2The winners and losers of the internet break-up 3Separating science fiction from reality in the human cloning debate 2Separating science fiction from reality in the human cloning debate 3
ICAD Purified Anti-Mouse clone Polyclonal, Isotype Rabbit Ig, 200 µl Consult technical datasheet for details.
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications).
Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014).
Naphthol Blue Black, CI 20470
Biology Products: